UBS Maintains Buy on Albemarle, Lowers Price Target to $175

Benzinga Newsdesk www.benzinga.com Negative 75.0%

Neg 75% Neu 0% Pos 0%

UBS analyst Joshua Spector maintains Albemarle (NYSE:ALB) with a Buy and lowers the price target from $205 to $175.

Comments

No comments yet. Be the first!